Page last updated: 2024-11-04

sulfathiazole and Myocarditis

sulfathiazole has been researched along with Myocarditis in 1 studies

Sulfathiazole: A sulfathiazole compound that is used as a short-acting anti-infective agent. It is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.
sulfathiazole : A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CZARNIECKI, W1
SOSZKA, AE1
SLIWOWSKI, A1

Other Studies

1 other study available for sulfathiazole and Myocarditis

ArticleYear
[Acute interstitial myocarditis of Fiedler caused by sulfathiazole].
    Polskie Archiwum Medycyny Wewnetrznej, 1962, Volume: 32

    Topics: Humans; Myocarditis; Sulfathiazole; Sulfathiazoles

1962